Statistics

Total Visits

Views
Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)217

Select a period of time:

Number of views in the range

Views
Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (Affirm)140

Views

Views
December 202551
January 202660
February 20268
March 20269
April 20268
May 20263
June 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
France122
United States6
Argentina2
China1
Colombia1
Guyana1
Italy1
Morocco1
Mexico1
Peru1
 

Top cities views

Views
Arequipa1
Chicago1
Georgetown1
Istanbul1
La Carlota1
Los Angeles1
Medellín1
Resistencia1
Reynosa1
Salé1